Pharmacists are in a unique position to affect the lives of people living with diabetes. The pharmacist can identify people at risk, screen for pharmacotherapy problems, and give encouragement between physician visits. The medication knowledge that the clinical pharmacist brings to the health care team results in decreased costs, improved glycemic control, and greater adherence to ADA standards of care.
Ada.Clinical practice recommendations 2003. Diabetes Care.2003;26:917-932.
5.
Cranor C.Outcomes of Ashville Project. PharmTimes. October 1998;(suppl):19-25.
6.
Ada.Clinical practice recommendations 2007. Diabetes Care.2007;30(suppl): S6-S12.
7.
Kroon LA, Coleman LT, Koda-Kimble MAThe management of type 2 diabetes mellitus: a call to action for pharmacists . US Pharm. May1997; 22(suppl):1-18.
8.
Coast-Senior EA, Kroner BA, Kelley CI, Trilli LEManagement of type 2 diabetes patients by a pharmacist in primary clinics. Ann Pharmacother.1998;32:636-641.
9.
Jaber LA, Halapy H., Fernet M., Jummalapalli S.Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother.1996;30:238-243.
10.
Yanchick JKImplementation of a drug therapy monitoring clinic in a primary care setting. Am J Health Syst Pharm.2000;57(suppl 4):S30-S34.
